
Venlasys 75mg Capsule ER
Marketer
Neosys Medicare
Salt Composition
Venlafaxine (75mg)
Overview Venlasys 75mg Capsule ER
Desvenlafaxine extended-release 75mg capsules treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, fidgeting, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Desvenlafaxine 75mg ER with food, consistently at the same time daily for steady blood levels. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even if feeling improved; abruptly ceasing treatment could worsen symptoms. Potential side effects include queasiness, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, excessive sweating, and sexual problems. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until effects are known. Most side effects are transient and self-limiting. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose kidney, heart, or liver issues, and any history of seizures to your doctor. Report any unusual mood shifts, worsening depression, or suicidal ideation immediately.
Primary Ingredients of Venlasys 75mg Capsule ER
No text provided to rephrase.
Uses of Venlasys 75mg Capsule ER
Mood disorders encompassing sadness and worry
Major Benefits of Venlasys 75mg Capsule ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 75mg Venlasys extended-release capsule whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Venlasys 75mg Capsule ER:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Venlasys 75mg Capsule ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Venlasys 75mg Extended-Release Capsules should be administered with a meal.
How Venlasys 75mg Capsule ER works:
Extended-release Venlasys 75mg capsules function by elevating brain concentrations of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Venlafaxine Extended-Release 75mg capsules and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Venlasys 75mg capsules may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Venlasys 75mg capsules are likely unsafe for breastfeeding mothers. Existing data indicates potential transfer to breast milk with possible infant harm. Infants should be observed for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Driving may be impaired by Venlasys 75mg Extended-Release Capsules, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.
KidneyCAUTION
Extended-release Venlasys 75mg capsules require careful administration for individuals with impaired renal function. Dosage modification of Venlasys 75mg extended-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Venlasys 75mg capsules require careful administration for individuals with hepatic impairment. Dosage modification of Venlasys 75mg extended-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Venlasys 75mg Capsule ER :
Should you forget a Venlasys 75mg extended-release capsule, take it immediately upon remembering. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Venlasys 75mg Capsule ER
| Label | Value |
|---|---|
| Chemical Type | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
